EVALUATING ORGANIZATIONAL DESIGN TO ASSURE TECHNOLOGY-TRANSFER - THE CASE OF THE COMMUNITY CLINICAL ONCOLOGY PROGRAM
EVALUATING ORGANIZATIONAL DESIGN TO ASSURE TECHNOLOGY-TRANSFER - THE CASE OF THE COMMUNITY CLINICAL ONCOLOGY PROGRAM
复制标题
DOI：
10.1093/jnci/81.22.1717
复制
发表时间：
1989-11-15
期刊：
影响因子：
--
通讯作者：
GOLDMAN, J
中科院分区：
文献类型：
--
作者：
KALUZNY, AD;RICKETTS, T;GOLDMAN, J
目前的组织绩效理论被用来指导北卡罗来纳大学教堂山分校卫生服务研究中心和伊利诺伊大学调查研究实验室的研究人员对国家癌症研究所的社区临床肿瘤学项目（CCOP）进行评估，并得出政策选择以加强项目运作。CCOP代表了一种创新机制，旨在提高患者对III期临床试验的累积，使社区肿瘤学家参与临床研究，并有可能向远离癌症中心和研究型医疗中心的地区传播最先进癌症治疗的新信息。在对CCOP第二阶段的评估中，研究了52个目前资助的CCOP和17个研究基地使患者接受癌症治疗和癌症控制研究方案的能力，它们对CCOP社区癌症治疗实践模式的影响，以及它们对初级保健医生癌症控制意识和活动的影响。该评价采用选定的组织视角来描述可能影响CCOP绩效的CCOP、研究基地和研究所的组织内和组织间特征。这种组织方法将CCOP的收益和影响与项目设计和管理策略的可控方面联系起来，这些方面可以通过国家癌症研究所指导的政策来改变。这些政策包括用于选择CCOPs的标准，研究基地在制定和执行治疗和癌症控制研究规程方面的作用，以及应计信用额的使用。[J]中华癌症杂志（英文版），2009。
Current theories of organizational performance are used to guide researchers at the Health Services Research Center of the University of North Carolina at Chapel Hill and the University of Illinois Survey Research Laboratory in the evaluation of the National Cancer Institute's Community Clinical Oncology Program (CCOP) and to derive policy options to enhance program operations. CCOP represents an innovative mechanism designed to improve the accrual of patients to phase III clinical trials, involve community-based oncologists in clinical research, and potentially to disseminate new information on the state-of-the-art cancer treatment to areas distant from cancer centers and research-oriented medical centers. Examined in this evaluation of the second phase of the CCOP are the ability of the 52 currently funded CCOPs and 17 research bases to accrue patients to cancer treatment and cancer control research protocols, their influence on the patterns of practice for cancer treatment in CCOP communities, and their influence on cancer control awareness and activity among primary care physicians. The evaluation applies selected organizational perspectives to describe the intraorganizational and interorganizational characteristics of the CCOPs, research bases, and the Institute that may affect the performance of the CCOP. This organizational approach relates the accrual and influence of the CCOP to controllable aspects of the program's design and management strategies that can be changed through policies directed by the National Cancer Institute. These policies include the criteria used to select CCOPs, the role of research bases in the development and implementation of treatment and cancer control research protocols, and the use of accrual credits. [J Natl Cancer Inst 81: 1717–1725, 1989]